On September 1, 2025, Eli Lilly, the big drug company that makes Mounjaro (tirzepatide), shocked UK patients by raising the price of Mounjaro in all UK pharmacies.
The cost for private users went up a lot overnight, sometimes by more than 150%, depending on how strong the dose was.

The announcement was part of a company-wide effort to make prices the same, but for thousands of private users who use Mounjaro to lose weight and manage their Type 2 diabetes, this sudden rise felt like a punch in the gut.

Fixed prices still protect NHS contracts, but private patients, like those who buy from Boots, Lloyds, and independent online pharmacies, have been hit the hardest.

In the middle of this crisis, GLP JOURNEY has stepped up as a smart, cheap, and long-lasting choice.
The Tirzepatide and Retatrutide pens have the same active ingredients and work the same way, but they are up to 200% cheaper.
This means that people in the UK can keep getting treatment without worrying.

This article explains what caused the Mounjaro price to rise, how it affects real people, and why GLP JOURNEY is now the country’s trusted, lower-cost choice.

What Happened to the Price of Mounjaro in the UK?

Mounjaro became one of the UK’s most popular injectable treatments in 2025.
It was marketed as a drug that could help people lose a lot of weight, keep their blood sugar levels stable, and reset their metabolism.
It was said to be a game-changer for both Type 2 diabetes and weight loss.

But that success led to a demand that had never been seen before.
Pharmacies couldn’t keep up.
The waiting lists got longer every week.
Eli Lilly blamed “supply constraints” and said that a big price change would happen on September 1, 2025.

Prices for Mounjaro went up by 45% to 170%, depending on the dose.
The lower strengths went up a little, but the higher doses, like 10 mg, 12.5 mg, and 15 mg, went up the most.
The company said the change was part of its “global pricing alignment” to match European markets.
However, UK patients saw it as a way to raise prices when living costs were high.

When budgets were already tight, it quickly became impossible to pay £300–£370 for each pen.
Patients in the NHS were protected by procurement contracts, but people who used the service privately had to pay for everything.
Pharmacies and clinics had to pass on these costs, and many people who had been using them for a long time had to choose between paying more or not using them at all.

A lot of people got mad right away.
Some patients began to miss doses or wait longer between doses to make their pens last longer.
Some people looked for cheaper options like GLP JOURNEY, which had the same molecule but didn’t have the corporate markup.

Mounjaro Boots Price List (October 2025)

Boots, one of the UK’s largest pharmacy chains, quickly changed its prices to match the new ones from the maker.
Their online Mounjaro listings showed the following average retail prices by October 2025, compared to GLP JOURNEY’s cheap Tirzepatide options:

These numbers tell a very clear story.
Every pen that GLP JOURNEY customers buy saves them between £60 and £180.
People who are in therapy all the time can save thousands of pounds each year.

For instance:

It would cost more than £4,000 a year at Boots if someone took 10 mg a week.
GLP JOURNEY costs about £2,000 for the same dose, which is half as much but works just as well.

This low price doesn’t just mean value; it also means access, sustainability, and not having to pay high drug prices.

GLP JOURNEY Has Cheap Tirzepatide and Retatrutide Pens

GLP JOURNEY sells research-grade Tirzepatide pens that have the same dual GLP-1/GIP receptor agonist as Mounjaro.
The way each pen is made is clean and perfect, so they all have the same effects on metabolism — lowering appetite, making insulin work better, and speeding up fat metabolism.

GLP JOURNEY also sells Retatrutide pens, which are the next generation of “triple agonist” compounds that are getting a lot of attention around the world for their amazing fat-loss results.
Early research suggests that Retatrutide may be better than Tirzepatide at reducing body fat and improving insulin function.

Why People Are Changing

• Prices are up to 200% lower than the new prices for Mounjaro

• Same active ingredient (Tirzepatide) means the same clinical results

• There are different dose options for each strength of Mounjaro

• Prices are clear, with no extra fees or markups from the pharmacy

• Fast, private delivery in the UK

• Great customer service for people who use it a lot

The only thing GLP JOURNEY wanted to do was make advanced metabolic peptides available to everyone who needed them.
Their pricing model makes sure that the products are safe, pure, and effective while still being cheap.

What Are the Benefits of GLP JOURNEY Over Mounjaro?

The real question is: Why pay more for the same thing when both products have the same molecule?

These are the main reasons why so many people are switching:

1. The Active Ingredient Is the Same, But the Price Hasn’t Gone Up

Tirzepatide is a proven dual GLP-1 and GIP receptor agonist that is in both Mounjaro and GLP JOURNEY pens.
The pharmacology is the same; it controls metabolism, blood sugar, and appetite.
The price is the only thing that changes.

2. A Lot of Money Saved

After Eli Lilly raised prices in September 2025, UK pharmacies sold Mounjaro pens for between £336 and £372.
GLP JOURNEY sells the same strengths for £169 to £189, which saves users between 40% and 200%, depending on how much they take and how long they take it.

3. Use That Lasts a Long Time

It takes time to manage diabetes and lose weight.
You can keep getting treatment that is affordable over the long term and see real, measurable progress instead of stopping halfway because you can’t afford it.

4. Open and Based in the UK

With GLP JOURNEY, there are no hidden fees, subscription traps, or upsells.
Prices are clear, and orders are filled safely from the UK.

5. Options for the Next Generation

GLP JOURNEY does more than just Tirzepatide.
The Retatrutide range lets you try out the next step in GLP-1 therapy early:
a triple-agonist compound that works on three metabolic pathways at once to get better results.

6. Community, Help, and Results

GLP JOURNEY doesn’t just sell pens; it also creates a useful online community.
People who use the service give each other advice, keep track of their progress, and cheer each other on.
Regular pharmacies don’t do this.

People Who Keep Their Money

“Boots wanted £336 for my 10 mg Mounjaro pen, but GLP JOURNEY only charged £169.
I couldn’t believe how different it was!”
— Sarah, Leeds

“I paid almost £300 for my 7.5 mg Mounjaro pen at Boots.
GLP JOURNEY sold it for £159.
Same results, but half the price.”
— James, Manchester

“I paid £350 for the 12.5 mg Mounjaro pen I got from Boots.
GLP JOURNEY charged £179 for it.
It helped me save a lot of money!”
— Chloe, Brighton

These testimonials show a pattern across the country: the same level of effectiveness, ongoing progress, and huge financial relief.

Lower quality doesn’t mean lower cost; it means you can finally stick to your budget without giving up quality.

Less Money = Progress Over Time

When it comes to metabolic therapy, staying on track is very important.
If patients miss doses or stop treatment too soon, they can lose months of progress.
This makes their blood sugar levels change and their appetite come back.

A lot of people have had to cut back on their pens because of the new Mounjaro prices.
They do this by stretching their injections, cutting their doses in half, or skipping weeks altogether.
People get angry, stuck, and then they gain weight again.

GLP JOURNEY has fixed this problem.
Because the prices are fair, users can stay on track, make steady progress, and reach their goals without having to make any sacrifices.

For Example — Annual Cost Comparison

Every year, you save £2,012.

You can use that money for months of more treatment or put it back into your health, nutrition, and exercise.
Affordable therapy means results that last, not just quick fixes.

Join the GLP JOURNEY Movement

The price rise in September 2025 made one thing clear: UK patients should be able to get treatments that can change their lives without companies raising prices.

GLP JOURNEY fills that gap with a model that is direct, clear, and cheap, and that gives people what they really need: results, consistency, and peace of mind.

When you buy a pen from GLP JOURNEY, you’re not just getting a pen.
You’re joining a movement that is based on science, honesty, and low prices.

A Quick Look at What GLP JOURNEY Can Do for You

• Prices can be as much as 200% lower than what Mounjaro sells

• Same molecule of Tirzepatide, same results

• Optional Retatrutide pens that work better than ever

• Prices in the UK that are clear, with no extra charges

• Help with education and community support

• Fast, private shipping and easy to order again

Be in charge of your health, money, and future.
GLP JOURNEY shows that getting better health doesn’t have to cost a lot of money.

Questions That Are Often Asked

Q: Why did Mounjaro prices rise in 2025?

On September 1, 2025, Eli Lilly raised prices in the UK to match those in other European markets.
The result was a rise of up to 170%, with private buyers paying more than £350 each for high-dose pens.

Q: Is Mounjaro the same as GLP JOURNEY?

Yes. Both of them have Tirzepatide, which is a drug that works on both GLP-1 and GIP receptors.
The name and price are the only things that are different; the mechanism, results, and dosing are all the same.

Q: Is it safe for me to go from Mounjaro to GLP JOURNEY?

Yes, of course.
A lot of people switch without any problems as long as they keep taking the same amount each week.
It’s best to stick to your injection schedule without taking any breaks.
If you need to make any changes, talk to your doctor.

Q: How much less does GLP JOURNEY cost than Mounjaro?

Depending on how strong it is, GLP JOURNEY can be 40% to 200% cheaper.
For instance, Boots sells the 10 mg pen for £336, but GLP JOURNEY sells it for £169.

Q: What is Retatrutide, and how does it compare?

Retatrutide is a new peptide that acts as a triple agonist on GLP-1, GIP, and glucagon receptors.
It works better than Tirzepatide to speed up metabolism and help people lose weight.
GLP JOURNEY lets you use this promising new compound for research purposes before anyone else.

Q: Is GLP JOURNEY located in the UK?

Yes, GLP JOURNEY is based in the UK and does business with customers in both the UK and the EU.
Fast order processing, tracked delivery, and helpful customer service.

Q: Are the GLP JOURNEY items real and have been checked for quality?

To make sure that every GLP JOURNEY pen is pure, sterile, and has the right amount of medicine in it, it is made to strict standards.

Q: Do I need a doctor’s note?

You can only use GLP JOURNEY pens for research.
Users should talk to a qualified healthcare professional about the medical treatment they have been given.

Since 2025, the price of Mounjaro has gone up so much that it is now a luxury item instead of a cheap therapy.
People don’t have to give up on progress or pay too much, though.

GLP JOURNEY is a cheap, useful, and research-grade choice.
It gives you consistency and power, but the branded version is harder to find now.
It has the same Tirzepatide formulas, prices that are easy to understand in the UK, and savings of up to 200%.

“Boots wanted £336 for my 10 mg Mounjaro pen, but GLP JOURNEY only charged £169.
What a huge change.”
— Sarah, Leeds

The message is clear: why pay more for the same molecule?

Join the thousands who have already made the switch and make your GLP JOURNEY one that lasts — not one that causes money problems.